Palatin Technologies Inc (PTN): EPS (Diluted)
-$2.96
Year ended 2026-06-30
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$2.96 | n/m | 2026-09-28, From 2025-07-01 |
| 2025-06-30 | -$32.15 | n/m | 2026-09-28, From 2024-07-01 |
| 2024-06-30 | -$101.16 | n/c | 2025-09-23, From 2023-07-01 |
| No annual figure between 2020-06-30 and 2024-06-30. | |||
| 2020-06-30 | -$0.10 | n/m | 2020-09-25, From 2019-07-01 |
| 2019-06-30 | $0.16 | +33.3% | 2020-09-25, From 2018-07-01 |
| 2018-06-30 | $0.12 | 0.0% | 2020-09-25, From 2017-07-01 |
| 2017-06-30 | $0.12 | n/c | 2020-09-25, From 2016-07-01 |
| 2016-06-30 | -$0.33 | n/a | 2018-09-13, From 2015-07-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Palatin Technologies Inc (PTN) | 2026-06-30 | -$2.96 | n/m |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | 2025-12-31 | -$14.57 | n/m |
| Evommune, Inc. (EVMN) | 2025-12-31 | -$11.22 | n/m |
| CV Sciences, Inc. (CVSI) | 2025-12-31 | -$0.01 | n/m |
| Pyxis Oncology, Inc. (PYXS) | 2025-12-31 | -$1.28 | n/m |
| Emmaus Life Sciences, Inc. (EMMA) | 2025-12-31 | -$0.12 | n/m |
| Arbutus Biopharma Corp (ABUS) | 2025-12-31 | -$0.17 | n/m |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | -$0.80 | n/m |
| Prelude Therapeutics Inc (PRLD) | 2025-12-31 | -$1.29 | n/m |
Compare PTN, TNXP, EVMN, CVSI side by side · Screen every company in Pharmaceutical Preparations ↗